- Published on
Infectious Disease and Microbiology – Cryptosporidiosis
Cryptosporidiosis is caused by Cryptosporidium parvum and related species, including Cryptosporidium hominis and Cryptosporidium meleagridis. Cryptosporidium is an intracellular protozoan parasite that infects epithelial cells, primarily in the gastrointestinal tract. In immunocompetent individuals, infection typically causes self-limited watery diarrhea. However, in patients with advanced HIV infection or other forms of immunosuppression, it can lead to severe, protracted, and potentially life-threatening diarrhea.
Cryptosporidium is ubiquitous worldwide. In the United States, more than 300,000 cases occur annually. Seroprevalence rates reach up to 25% in industrialized countries and as high as 75% in developing regions. Transmission increases during warmer months in temperate climates. Large waterborne outbreaks have occurred, including the well-known outbreak in Milwaukee, Wisconsin, linked to contaminated municipal water. Contamination is often associated with agricultural runoff from dairy farms or other livestock operations. The organism is resistant to routine chlorination, making waterborne transmission particularly problematic.
Risk factors include advanced HIV infection (especially CD4 count <100 cells />mu;L), other immunosuppressive states, young children in developing countries, and animal handlers. Transmission occurs primarily through ingestion of oocysts in fecally contaminated water or food. Oocysts are highly resilient and may survive in the environment for up to 18 months. Ingestion of fewer than 1,000 oocysts can result in disease. Person-to-person transmission occurs in childcare centers, hospitals, through sexual contact, and via contaminated swimming pools. Transmission from pets and farm animals is also possible.
After ingestion, oocysts release sporozoites that infect epithelial cells of the small intestine. The parasite resides intracellularly but extracytoplasmically at the brush border of the mucosa. The entire life cycle occurs within a single host. Infection leads to impaired absorption, resulting in watery diarrhea and malabsorption. In immunocompromised patients, dissemination may occur, involving the biliary tree or respiratory tract.
The incubation period ranges from 7 to 10 days. In immunocompetent individuals, watery diarrhea lasts from several days up to one month and may be accompanied by crampy abdominal pain and low-grade fever. Vomiting is less common than with other causes of gastroenteritis. In patients with advanced immunosuppression, especially those with CD4 counts below 50 cells/μL, diarrhea may be profuse and exceed 10–15 liters per day. Weight loss, malnutrition, and recurrent disease occur in up to 40% of cases. Respiratory involvement may produce dyspnea.
Physical examination findings are nonspecific. In severe or chronic cases, signs of dehydration and wasting due to malabsorption may be evident.
Diagnosis is made by stool examination. Modified acid-fast staining demonstrates red or pink oocysts against a blue-green background. Immunofluorescent antibody staining is considered the gold standard. Enzyme-linked immunosorbent assays (ELISA), immunochromatographic tests, and PCR assays are also available and more sensitive than routine microscopy. Leukocytosis is uncommon, and fecal leukocytes or erythrocytes are typically absent. Malabsorption may result in abnormal D-xylose testing, elevated alkaline phosphatase levels, and low vitamin B12 levels. Imaging studies are nonspecific but may show ileus patterns or bowel wall edema. Biliary involvement may present with dilated intrahepatic or extrahepatic bile ducts, and respiratory involvement may show bilateral pulmonary infiltrates. Small intestinal biopsy reveals organisms attached to the brush border.
The differential diagnosis includes bacterial enteric infections such as Salmonella, Shigella, and Campylobacter; Clostridioides difficile infection; viral gastroenteritis; mycobacterial infections; other protozoal infections such as Giardia, Cyclospora, Isospora, and Microsporidia; and cytomegalovirus colitis.
Treatment depends on immune status. In immunocompetent individuals, the illness is typically self-limited and supportive care with hydration is sufficient. Nitazoxanide is effective in treating diarrhea in non-immunocompromised patients and is given for three days. In immunocompromised patients, especially those with AIDS, antiparasitic drugs have limited proven efficacy. Nitazoxanide has been used compassionately in such cases for extended durations. Paromomycin has shown variable results and may be combined with antimotility agents. Macrolides such as azithromycin and clarithromycin have some activity. Combination regimens (e.g., paromomycin plus azithromycin) and rifaximin have also been used.
Supportive care is critical, particularly in HIV-infected patients. Antimotility agents such as loperamide or diphenoxylate/atropine may help reduce stool frequency. Octreotide can decrease stool output without eradicating the organism. Immune reconstitution with effective antiretroviral therapy is the most important intervention in patients with AIDS and often leads to clinical improvement. Hospitalization and intravenous fluids are required for severely dehydrated patients, especially children.
Prognosis is generally good in immunocompetent individuals and in patients with HIV infection whose CD4 counts exceed 150 cells/μL. In advanced HIV infection, however, protracted diarrhea can be life-threatening. Complications include acalculous cholecystitis, sclerosing cholangitis, pancreatitis, tracheitis, and bronchitis when the respiratory tract is involved.
0 Comments
